EX-4.25 2 dex425.htm XYREM LICENSE AND DISTRIBUTION AGREEMENT DATED AS OF OCTOBER 29 CONFIDENTIAL EXECUTION VERSIONLicense and Distribution Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 Jurisdiction* CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN * .
ORPHAN MEDICAL INC. AND CELLTECH PHARMACEUTICALS LTD. XYREM® LICENSE AND DISTRIBUTION AGREEMENTLicense and Distribution Agreement • June 25th, 2004 • Celltech Group PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 25th, 2004 Company Industry JurisdictionThis LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of October 29, 2003 (“Effective Date”), by and between Orphan Medical, Inc., a corporation having its principal place of business at 13911 Ridgedale Drive, Suite 250, Minnetonka, Minnesota 55305, USA (together with its Affiliates, “Orphan Medical”), and Celltech Pharmaceuticals, Ltd., a biopharmaceutical company organized under the laws of England having its principal place of business at 208 Bath Road, Slough, Berkshire SL1 3WE, United Kingdom (together with its Affiliates, “Celltech”).